1. Home
  2. FOR vs RXRX Comparison

FOR vs RXRX Comparison

Compare FOR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$29.07

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.36

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
RXRX
Founded
2005
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
FOR
RXRX
Price
$29.07
$3.36
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$32.67
$7.50
AVG Volume (30 Days)
100.4K
15.3M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.79
EPS
1.63
N/A
Revenue
$1,662,400,000.00
$74,681,000.00
Revenue This Year
$0.34
$12.11
Revenue Next Year
$7.73
$82.52
P/E Ratio
$18.04
N/A
Revenue Growth
10.14
26.92
52 Week Low
$22.81
$2.77
52 Week High
$32.06
$7.18

Technical Indicators

Market Signals
Indicator
FOR
RXRX
Relative Strength Index (RSI) N/A 58.31
Support Level N/A $2.87
Resistance Level N/A $4.03
Average True Range (ATR) 0.00 0.15
MACD 0.00 0.03
Stochastic Oscillator 0.00 92.24

Price Performance

Historical Comparison
FOR
RXRX

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Share on Social Networks: